Header Logo

Connection

Joan Walker to Hydroxamic Acids

Back to Details
This is a "connection" page, showing publications Joan Walker has written about Hydroxamic Acids.
Joan Walker
Connection Strength
0.025
Hydroxamic Acids
  1. A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 May; 125(2):367-71.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.